January 09, 2020
MEXICO CANNABIS UPDATE #12
2019 Cannabis Year in Review
Following the 2017 amendments to the General Health Law (Ley General de Salud, or “LGS”) to legalize medical and scientific use of cannabis products with up to 1% of tetrahydrocannabinol, and then the 2018 landmark resolutions issued by the Mexican Supreme Court of Justice regarding cannabis recreational use, legalization advocates set great expectations for 2019.
December 06, 2019
MEXICO CANNABIS UPDATE #11
Extension for Passage of New Cannabis Law Granted
Just before the October 31, 2019 deadline set by the Mexican Supreme Court (SCJN) for the Senate to pass the new Law for Cannabis Regulation (Ley de Regulacion del Cannabis), the Senate, through its presiding Chairman Sen. Monica Fernandez, asked the nation’s highest court to grant an extension in order to allow for a more thorough review of the feedback received from different sets of legalization advocates.
October 22, 2019
MEXICO CANNABIS UPDATE #10
Draft of New Cannabis Law Issued
Just before midnight on October 17, 2019, the Senate’s Justice Committee issued what would purportedly be the draft of the new Law for Cannabis Regulation (Ley de Regulacion del Cannabis) to be submitted to general vote this week before the October 23 deadline.
October 7, 2019
MEXICO CANNABIS UPDATE #9
Preview of Medical Cannabis Rules by COFEPRIS
Dr. Jose A. Novelo, director of the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) appeared before the Mexican Senate’s Health Committee to discuss the current government’s public health agenda. Not surprisingly, one of the main subjects discussed was the status of the long-awaited regulations for medical cannabis products. Dr. Novelo mentioned that COFEPRIS’ focus is mainly on health and sanitary risks, including scientific and research activities focused on public health needs, not recreational use.
October 2, 2019
Participation at the American Bar Association’s Cannabis Conference
On September 19 and 20, 2019 the American Bar Association held its first-ever conference on cannabis, titled “From Regs to Riches: Navigating the Rapidly Emerging Fields of Cannabis and Hemp Law”. Our partner, Luis Armendariz, participated at the panel on the topic “The global commoditization of marijuana and hemp: where in the world is cannabis headed?” speaking about the current status of regulation in Mexico and how cannabis and hemp companies can plan for their market entry.
September 30, 2019
Mexico Cannabis update #8
New Cannabis Bills Introduced to Senate
In the past months, additional bills have been introduced in the Mexican Senate with the intention or regulating cannabis and hemp. As of today, a total of 13 initiatives o proposals to amend existing or enact new laws have been filed in the Senate in addition to another number of bills in the lower house of congress. (Click here to see a note by Marijuana Business Daily where Luis Armendariz is quoted on this.)
Regulación del CBD
Perspectiva general en México
Poco a poco se hace de mayor conocimiento que el cannabi-diol, mejor conocido como CBD que cuenta con múltiples usos.
En palabras de David DiSalvo, colaborador del sitio online de Forbes, "existe un mercado potencial de hasta 20,000 millones de dólares americanos". Aquí es donde podemos vizualizar que hay un lugar para los productos medicinales, cosméticos y paliativos en México, considerando que se trata de un país vecino a los Estados Unidos.
September 19, 2019
Luis Armendariz quoted by Marijuana Business Daily
Mexico has over a month to legalize recreational cannabis, with 10 proposed laws in the mix
With a court-ordered deadline to legalize recreational cannabis in Mexico approaching next month, parliamentarians have no fewer than 10 proposed laws to scrutinize. It is anyone’s guess which one will come out on top. But the clock is ticking, with lawmakers facing a little more than a month to pass legalization legislation.
August 22, 2019
Supreme Court urges Government to issue Cannabis Guidelines.
The Mexican Supreme Court of Justice (SCJN) unanimously approved Justice Eduardo Medina Mora’s proposed draft of a ruling that orders the Health Secretariat and COFEPRIS to issue the necessary regulations for the medicinal use of cannabis and its derivatives within a 180 business days term. The ruling was issued after establishing that the Executive power breached the mandate of the June 2017 reform to the General Health Law that gave them 6 months to issue such regulations.
August 14, 2019
Partnership with InStrag for Intelligence Reports and Lobbying Services
We are happy to announce our new partnership with InStrag, a public affairs firm based out of Mexico City. Jointly, we have put together a set of products and services designed to help foreign companies understand the status and development of cannabis and hemp regulation process in Mexico as well as provide the insight and capabilities to participate in such discussions through direct engagement with the authorities at both the Federal Congress and Executive Government.
The following reports and services are now available:
- The Initial Cannabis and Hemp in Mexico Report
- The biweekly Mexican Cannabis Intelligence Reports
- Lobbying and Engagement with Authorities
April 27, 2019
Cancellation of COFEPRIS Guidelines.
On March 26, 2019, the Federal Commissioner for the Protection of Sanitary Risks (“COFEPRIS”), Mr. Jose A. Novelo Baeza, announced the revocation of the guidelines issued on October 30, 2018, for the import and sale of products with cannabis and its derivates.
The grounds for such action were largely based on omitted legal formalities for the issuance of government guidelines for general application, such as a publication beforehand in the Federal Official Gazette (Diario Oficial de la Federacion) and regulatory impact analysis by the Mexican Commission of Regulatory Improvement (Comision Nacional de Mejora Regulatoria). Reference was also made to the contradiction between import/export tax rules, which prohibit the importation of cannabis plants, and the now-revoked guidelines, which provided for the granting of import permits.
March 25, 2019
Status of Proposed and Existing Regulation.
On March 19, 2019, the Secretariat of Health issued a press release informing the appearance of Secy. Jorge Alcocer before the Senate’s Health Committee to discuss the nation’s public health agenda. Among the top items was the status on the guidelines issued on October 30, 2018 by the Federal Commission for the Protection of Sanitary Risks (“COFEPRIS”) for the import and sale of products with cannabis and its derivates (reported here).
January 15, 2019
Luis Armendariz quoted by the Daily Business Journal (a law.com publication): Is Latin America the Next Big (Legal) Marijuana Market?
With the election last summer of a new president and a ruling by Mexico’s Supreme Court in October, Mexico may be the next country, following Canada, to legalize marijuana.
The ruling by Mexico’s high court marked the fifth time that prohibition on recreational marijuana consumption had been ruled unconstitutional. The number of rulings is significant, as five rulings create a precedent that applies to all of Mexico’s courts.
January 9, 2019
2019 Outlook for Cannabis in Mexico
Even though the process for cannabis legalization in Mexico started a few years ago, 2018 will be remembered as the year when cannabis activists saw efforts materialized in groundbreaking supreme court resolutions, regulatory amendments and proposed legislation.
November 22, 2018
Mexico issues first authorizations for cannabis products
Mexico issues first authorizations for cannabis products The Secretary of Health, through the Federal Commission for the Protection of Sanitary Risks (“COFEPRIS”) announced yesterday the authorization for the first 38 products with cannabis and its derivates, with no THC or psycho-active effects, to enter the Mexican market within the next five weeks.
November 14, 2018
The path towards a legal Cannabis industry in Mexico
Following significant regulatory trends in other countries such as neighbors the United States and Canada, Mexico began taking steps toward allowing the use of cannabis. The legislative process to amend certain provisions of the General Health Law (Ley General de Salud, or “LGS”) resulted in the June 19, 2017 publication of amendments1 acknowledging the therapeutic benefits of tetrahydrocannabinol (“THC”), opening the door to the research and academic study of medicinal cannabis and, subject to a permit by the Federal Commission for the Protection of Sanitary Risks (“COFEPRIS”), allowing the importation of medications containing THC. At that time, cannabis products without a sanitary license, self-production, harvest, and possession of cannabis were still prohibited.
August 3, 2018
Note published in El Financiero, a nationwide financial journal, regarding our client, Windstar Energy Resources, and its importation and distribution of refined products (gasoline and diesel).
Our firm recently advised Radians Inc. in the due diligence and acquisition of Neese de Mexico, local operation owned by Neese Industries Inc.
March 6, 2018
Note on the mixed-use building called “Torre Santa Fe”, where our firm participates as legal advisor.
14 de noviembre de 2016
Publicación del Lic. Luis Armendáriz en el boletín de agosto de la Sección de Energía, Medio Ambiente y Recursos Naturales, de la American Bar Association, sobre actualización legal en la importación de gasolina, diésel y gas licuado de petróleo:
3 de abril de 2016
Portada de la revista PRO Magazine Chihuahua donde el Lic. Luis Armendariz aparece con sus compañeros de mesa directiva de la Asociación Nacional de Abogados de Empresa, Colegio de Abogados, A.C., Capítulo Chihuahua, el cual preside nuestro socio.
8 de octubre 2014
AALEGAL ahora es miembro de Lex Logística www.lexlogistica.com lo que ahora nos permite apoyar a nuestros clientes con trámites y juicios en 20 ciudades de México y 2 en Texas.
28 de agosto de 2014
Montage Legal Group aparece en la Revista Forbes. Frecuentemente trabajamos en proyectos para clientes de Montage en México y Latinoamérica, y a la vez nos apoyan para atender necesidades de nuestros clientes en Estados Unidos con excelentes abogados y a costos razonables.